London, September 28, 2011 - The international Structural Genomics Consortium (SGC) today announced $48.9 million in new funding has been attained. This renewed investment will allow the SGC to further develop its open access research program to support drug discovery and the development of new medicines.  The announcement comes as the SGC on June 30 successfully completed its second phase of funding (2007-2011).